CXCL14 and neoplasm: Next, we performed the co‐injection of 3T3 Cxcl14‐OE cells with mouse LLC cells, either subcutaneously or orthotopically, into immune‐competent C57BL/6 mice led to a substantial enhancement in tumour growth compared to the control group (Figures 4I–K and S2G,H).